Eidgenössische Ethikkommission für die Biotechnologie im Ausserhumanbereich EKAH

-»This version is meant for browsers without CSS support mainly for visually disabled users. For a more advanced layout please use a more recent browser like Firefox 2.0 or Internet Explorer 7.«-

Begin language selection

Begin main navigation

Begin sub navigation

Begin navigator

 



Begin content area

Nanobiotechnology. An ethical review

Contributions to Ethics and Biotechnology, Volume 1 (2006)

Andreas Bachmann focuses on a particularly promising area of nanotechnology– nanobiotechnology. The aims of this discipline are twofold: to apply nanotechnological developments in the life sciences (“Nano2Bio”) and to use biological materials and designs to produce technical nanosystems (“Bio2Nano”). After some preliminary remarks on nanotechnology in general, the first part of the review highlights the enormous potential of nanobiotechnology with reference to (possible) applications in biomimicry, medicine, agriculture and nutrition (“nanofood”). The second part gives an account of the ethical aspects of nanobiotechnology discussed in the literature, namely risks for humans and the environment, equity (“nano-divide”), military applications, data protection, nanomedicine and enhancement. The ethical problems specific to each aspect are explained – without offering answers – in such a way as to promote a more structured debate as to the ethically appropriate management of nanobiotechnology.


Last updated on: 30.01.2012




Autor

Philosopher and ethicist Andreas Bachmann is Operations Director of the “ethik im diskurs” consultancy (Zurich). His main interests are general ethics, risk ethics, care ethics and dementia ethics, and philosophy of the good life.



Federal Ethics Committee on Non-Human Biotechnology ECNH
info@ekah.admin.ch | Limitation of liability, Data protection and Copyright
http://www.ekah.admin.ch/index.php?id=60